Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORNbILL
2024-516021-32-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Relative adrenal insufficiency (CIRCI) comparing Hydrocortisone + fludrocortisone with Placebo of hydrocortisone + placebo of fludrocortisone (2 arms). Primary endpoint: Ventilator- and vasopressor-free days to day 30. Started Nov 2024; status: completed.
02
Drugs
hydrocortisonefludrocortisone
03
Conditions
Relative adrenal insufficiency (CIRCI)
Beyond the preview
Go deeper on 2024-516021-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516021-32-00.